Article
Change in serum KL-6 level from baseline is useful for predicting life-threatening EGFR-TKIs induced interstitial lung disease.
Respiratory research - 26 Jul 2011
Kawase Shigeo, Hattori Noboru, Ishikawa Nobuhisa, Horimasu Yasushi, Fujitaka Kazunori, Furonaka Osamu, Isobe Takeshi, Miyoshi Seigo, Hamada Hironobu, Yamane Takashi, Yokoyama Akihito, Kohno Nobuoki
Abstract excerpt
BACKGROUND: A high incidence of interstitial lung disease (ILD) has been reported in patients with advanced non-small cell lung cancer (NSCLC) treated with epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs), particularly in Japanese populations. A previous report from our laboratory demonstrated that KL-6 was a useful serum biomarker to assess the severity of drug-induced pneumonitis. Based...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
